1 Study Coverage 1.1 Adenovirus Vaccine Product Introduction 1.2 Global Adenovirus Vaccine Outlook 2017 VS 2022 VS 2028 1.2.1 Global Adenovirus Vaccine Sales in US$ Million for the Year 2017-2028 1.2.2 Global Adenovirus Vaccine Sales in Volume for the Year 2017-2028 1.3 United States Adenovirus Vaccine Outlook 2017 VS 2022 VS 2028 1.3.1 United States Adenovirus Vaccine Sales in US$ Million for the Year 2017-2028 1.3.2 United States Adenovirus Vaccine Sales in Volume for the Year 2017-2028 1.4 Adenovirus Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Adenovirus Vaccine in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Adenovirus Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Adenovirus Vaccine Market Dynamics 1.5.1 Adenovirus Vaccine Industry Trends 1.5.2 Adenovirus Vaccine Market Drivers 1.5.3 Adenovirus Vaccine Market Challenges 1.5.4 Adenovirus Vaccine Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Adenovirus Vaccine Market Segment by Type 2.1.1 Type 4 Vaccine 2.1.2 Type 7 Vaccine 2.2 Global Adenovirus Vaccine Market Size by Type 2.2.1 Global Adenovirus Vaccine Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Adenovirus Vaccine Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Adenovirus Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Adenovirus Vaccine Market Size by Type 2.3.1 United States Adenovirus Vaccine Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Adenovirus Vaccine Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Adenovirus Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Adenovirus Vaccine Market Segment by Application 3.1.1 Research & Academic Laboratories 3.1.2 Pharmaceutical & Biotechnology Companies 3.1.3 Others 3.2 Global Adenovirus Vaccine Market Size by Application 3.2.1 Global Adenovirus Vaccine Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Adenovirus Vaccine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Adenovirus Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Adenovirus Vaccine Market Size by Application 3.3.1 United States Adenovirus Vaccine Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Adenovirus Vaccine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Adenovirus Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Adenovirus Vaccine Competitor Landscape by Company 4.1 Global Adenovirus Vaccine Market Size by Company 4.1.1 Top Global Adenovirus Vaccine Manufacturers Ranked by Revenue (2021) 4.1.2 Global Adenovirus Vaccine Revenue by Manufacturer (2017-2022) 4.1.3 Global Adenovirus Vaccine Sales by Manufacturer (2017-2022) 4.1.4 Global Adenovirus Vaccine Price by Manufacturer (2017-2022) 4.2 Global Adenovirus Vaccine Concentration Ratio (CR) 4.2.1 Adenovirus Vaccine Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Adenovirus Vaccine in 2021 4.2.3 Global Adenovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Adenovirus Vaccine Manufacturing Base Distribution, Product Type 4.3.1 Global Adenovirus Vaccine Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Adenovirus Vaccine Product Type 4.3.3 Date of International Manufacturers Enter into Adenovirus Vaccine Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Adenovirus Vaccine Market Size by Company 4.5.1 Top Adenovirus Vaccine Players in United States, Ranked by Revenue (2021) 4.5.2 United States Adenovirus Vaccine Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Adenovirus Vaccine Sales by Players (2020, 2021 & 2022) 5 Global Adenovirus Vaccine Market Size by Region 5.1 Global Adenovirus Vaccine Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Adenovirus Vaccine Market Size in Volume by Region (2017-2028) 5.2.1 Global Adenovirus Vaccine Sales in Volume by Region: 2017-2022 5.2.2 Global Adenovirus Vaccine Sales in Volume Forecast by Region (2023-2028) 5.3 Global Adenovirus Vaccine Market Size in Value by Region (2017-2028) 5.3.1 Global Adenovirus Vaccine Sales in Value by Region: 2017-2022 5.3.2 Global Adenovirus Vaccine Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Adenovirus Vaccine Market Size YoY Growth 2017-2028 6.1.2 North America Adenovirus Vaccine Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Adenovirus Vaccine Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Adenovirus Vaccine Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Adenovirus Vaccine Market Size YoY Growth 2017-2028 6.3.2 Europe Adenovirus Vaccine Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Adenovirus Vaccine Market Size YoY Growth 2017-2028 6.4.2 Latin America Adenovirus Vaccine Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Adenovirus Vaccine Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Adenovirus Vaccine Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Teva Pharmaceuticals 7.1.1 Teva Pharmaceuticals Corporation Information 7.1.2 Teva Pharmaceuticals Description and Business Overview 7.1.3 Teva Pharmaceuticals Adenovirus Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Teva Pharmaceuticals Adenovirus Vaccine Products Offered 7.1.5 Teva Pharmaceuticals Recent Development 7.2 Barr Labs 7.2.1 Barr Labs Corporation Information 7.2.2 Barr Labs Description and Business Overview 7.2.3 Barr Labs Adenovirus Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Barr Labs Adenovirus Vaccine Products Offered 7.2.5 Barr Labs Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Adenovirus Vaccine Industry Chain Analysis 8.2 Adenovirus Vaccine Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Adenovirus Vaccine Distributors 8.3 Adenovirus Vaccine Production Mode & Process 8.4 Adenovirus Vaccine Sales and Marketing 8.4.1 Adenovirus Vaccine Sales Channels 8.4.2 Adenovirus Vaccine Distributors 8.5 Adenovirus Vaccine Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Adenovirus Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Adenovirus Vaccine Market Trends Table 3. Adenovirus Vaccine Market Drivers Table 4. Adenovirus Vaccine Market Challenges Table 5. Adenovirus Vaccine Market Restraints Table 6. Global Adenovirus Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Adenovirus Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Adenovirus Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Adenovirus Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Adenovirus Vaccine Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Adenovirus Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Adenovirus Vaccine Revenue Share by Manufacturer, 2017-2022 Table 13. Global Adenovirus Vaccine Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Adenovirus Vaccine Sales Share by Manufacturer, 2017-2022 Table 15. Global Adenovirus Vaccine Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Adenovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Adenovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenovirus Vaccine as of 2021) Table 18. Top Players of Adenovirus Vaccine in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Adenovirus Vaccine Product Type Table 20. Date of International Manufacturers Enter into Adenovirus Vaccine Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Adenovirus Vaccine Players in United States Market, Ranking by Revenue (2021) Table 23. United States Adenovirus Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Adenovirus Vaccine Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Adenovirus Vaccine Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Adenovirus Vaccine Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Adenovirus Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Adenovirus Vaccine Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Adenovirus Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Adenovirus Vaccine Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Adenovirus Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Adenovirus Vaccine Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Adenovirus Vaccine Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Adenovirus Vaccine Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Adenovirus Vaccine Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Adenovirus Vaccine Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Adenovirus Vaccine Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Adenovirus Vaccine Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Adenovirus Vaccine Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Adenovirus Vaccine Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Adenovirus Vaccine Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Teva Pharmaceuticals Corporation Information Table 43. Teva Pharmaceuticals Description and Business Overview Table 44. Teva Pharmaceuticals Adenovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Teva Pharmaceuticals Adenovirus Vaccine Product Table 46. Teva Pharmaceuticals Recent Development Table 47. Barr Labs Corporation Information Table 48. Barr Labs Description and Business Overview Table 49. Barr Labs Adenovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Barr Labs Product Table 51. Barr Labs Recent Development Table 52. Key Raw Materials Lists Table 53. Raw Materials Key Suppliers Lists Table 54. Adenovirus Vaccine Customers List Table 55. Adenovirus Vaccine Distributors List Table 56. Research Programs/Design for This Report Table 57. Key Data Information from Secondary Sources Table 58. Key Data Information from Primary Sources List of Figures Figure 1. Adenovirus Vaccine Product Picture Figure 2. Global Adenovirus Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Adenovirus Vaccine Market Size 2017-2028 (US$ Million) Figure 4. Global Adenovirus Vaccine Sales 2017-2028 (K Units) Figure 5. United States Adenovirus Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Adenovirus Vaccine Market Size 2017-2028 (US$ Million) Figure 7. United States Adenovirus Vaccine Sales 2017-2028 (K Units) Figure 8. United States Adenovirus Vaccine Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Adenovirus Vaccine Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Adenovirus Vaccine Report Years Considered Figure 11. Product Picture of Type 4 Vaccine Figure 12. Product Picture of Type 7 Vaccine Figure 13. Global Adenovirus Vaccine Market Share by Type in 2022 & 2028 Figure 14. Global Adenovirus Vaccine Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Adenovirus Vaccine Sales Market Share in Value by Type (2017-2028) Figure 16. Global Adenovirus Vaccine Sales by Type (2017-2028) & (K Units) Figure 17. Global Adenovirus Vaccine Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Adenovirus Vaccine Price by Type (2017-2028) & (USD/Unit) Figure 19. United States Adenovirus Vaccine Market Share by Type in 2022 & 2028 Figure 20. United States Adenovirus Vaccine Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Adenovirus Vaccine Sales Market Share in Value by Type (2017-2028) Figure 22. United States Adenovirus Vaccine Sales by Type (2017-2028) & (K Units) Figure 23. United States Adenovirus Vaccine Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Adenovirus Vaccine Price by Type (2017-2028) & (USD/Unit) Figure 25. Product Picture of Research & Academic Laboratories Figure 26. Product Picture of Pharmaceutical & Biotechnology Companies Figure 27. Product Picture of Others Figure 28. Global Adenovirus Vaccine Market Share by Application in 2022 & 2028 Figure 29. Global Adenovirus Vaccine Sales in Value by Application (2017-2028) & (US$ Million) Figure 30. Global Adenovirus Vaccine Sales Market Share in Value by Application (2017-2028) Figure 31. Global Adenovirus Vaccine Sales by Application (2017-2028) & (K Units) Figure 32. Global Adenovirus Vaccine Sales Market Share in Volume by Application (2017-2028) Figure 33. Global Adenovirus Vaccine Price by Application (2017-2028) & (USD/Unit) Figure 34. United States Adenovirus Vaccine Market Share by Application in 2022 & 2028 Figure 35. United States Adenovirus Vaccine Sales in Value by Application (2017-2028) & (US$ Million) Figure 36. United States Adenovirus Vaccine Sales Market Share in Value by Application (2017-2028) Figure 37. United States Adenovirus Vaccine Sales by Application (2017-2028) & (K Units) Figure 38. United States Adenovirus Vaccine Sales Market Share in Volume by Application (2017-2028) Figure 39. United States Adenovirus Vaccine Price by Application (2017-2028) & (USD/Unit) Figure 40. North America Adenovirus Vaccine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 41. North America Adenovirus Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 42. U.S. Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Canada Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Europe Adenovirus Vaccine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. Europe Adenovirus Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. Germany Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. France Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. U.K. Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Italy Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Russia Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Asia-Pacific Adenovirus Vaccine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 52. Asia-Pacific Adenovirus Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 53. China Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Japan Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. South Korea Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. India Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Australia Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. China Taiwan Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Indonesia Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Thailand Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Malaysia Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Latin America Adenovirus Vaccine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 63. Latin America Adenovirus Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 64. Mexico Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Brazil Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Argentina Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Middle East & Africa Adenovirus Vaccine Sales in Volume Growth Rate 2017-2028 (K Units) Figure 68. Middle East & Africa Adenovirus Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 69. Turkey Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Saudi Arabia Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. UAE Adenovirus Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Adenovirus Vaccine Value Chain Figure 73. Adenovirus Vaccine Production Process Figure 74. Channels of Distribution Figure 75. Distributors Profiles Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Teva Pharmaceuticals Barr Labs